Search
for
Sort by
Research 30 of 109
- Psychoactive drugs and skin
- UPLC-MS/MS method for the simultaneous quantification of caffeine and illicit psychoactive drugs in hair using a single-step high-speed grinding extraction – Insights into a cut-off value for caffeine abuse
- Psychoactive Agents in Dermatology
- Hair <i>Versus</i> Nails: Is There a Place for Other Keratin Matrices?
- The use of anabolic androgenic steroids: A focus on polypharmacy
- Endocannabinoid activation and polycystic ovary syndrome: A systematic review
- Novel potential avenues for the therapy of Tourette syndrome: Cannabinoid- and steroid-based interventions
- Topical use of systemic drugs in dermatology: A comprehensive review
- Cutaneous drug reactions
- Postmarketing Surveillance of New Antiepileptic Drugs: The Tribulations of Trials
- Drug Information Analysis Service
- Nociceptive and Nonnociceptive Roles of TRPV3 and Its “Druggability”
- Transethosomes: A Comprehensive Review of Ultra-Deformable Vesicular Systems for Enhanced Transdermal Drug Delivery
- How Biodegradable Polymers Can be Effective Drug Delivery Systems for Cannabinoids? Prospectives and Challenges
- Lifestyle drugs: concept and impact on society
- Micro-segmental hair analysis: detailed procedures and applications in forensic toxicology
- Systemic causes of hair loss
- Medicinal Chemistry of Drugs with <i>N</i>-Oxide Functionalities
- Can we teach old drugs new tricks?—Repurposing of neuropharmacological drugs for inflammatory skin diseases
- Are finasteride-related penile curvature/Peyronie’s disease Adverse Event Reports worthy of further clinical investigation? Disproportionality analysis based on both the Food and Drug Administration (FDA) and the European Medicines Agency (EMA) pharmacovigilance databases
- Psychological and psychiatric characterization of various groups of drugs users
- The Possible Role of Prescribing Medications, Including Central Nervous System Drugs, in Contributing to Male-Factor Infertility (MFI): Assessment of the Food and Drug Administration (FDA) Pharmacovigilance Database
- Ocfentanil testing in hair from a fatality case: Comparative analysis of a lock of hair versus a single hair fiber
- Cutaneous manifestations associated with substance use disorders
- Psychological interventions in the management of common skin conditions
- Skin cancer: understanding the journey of transformation from conventional to advanced treatment approaches
- Medicinal and cosmetic products used in treatment of hair loss
- Reporting on Adverse Clinical Events
- Poster Abstracts
- Effective holistic characterization of small molecule effects using heterogeneous biological networks